May 01, 2025

Phthalates Linked to Cardiovascular Mortality Globally

Researchers linked di-2-ethylhexylphthalate plastic exposure to over 350,000 cardiovascular deaths and 10 million years of life lost, supporting calls for international regulatory measures.

Conexiant

May 01, 2025

Modifiable Risk Factors Linked to Sudden Cardiac Arrest Incidence

A UK Biobank analysis identified 56 modifiable risk factors for sudden cardiac arrest; lifestyle improvements alone could prevent up to 18% of cases, with a total prevention potential of 63%.

Conexiant

April 30, 2025

New Phase III Data: Sotatercept for PAH

Sotatercept reduced the composite risk of death, lung transplantation, or hospitalization for worsening pulmonary arterial hypertension by nearly 75% compared with placebo in high-risk patients in a phase III trial.

Conexiant

April 29, 2025

New Drug Tames Resistant High Blood Pressure

Lorundrostat reduces blood pressure significantly in patients with treatment-resistant hypertension by targeting aldosterone production.

Conexiant

April 25, 2025

Multidimensional Sleep Health Affects Heart

Sleep is not a unitary physiologic experience, the AHA states in its new scientific statement, which redefines how physicians should assess sleep’s impact on cardiometabolic health.

Conexiant

April 23, 2025

Sense of Belonging 'Critical' for Workplace Retention

Individuals who reported a neutral level of satisfaction with their sense of belonging were approximately 3 times more likely to express an intent to leave, while those who were dissatisfied were 7 times more likely to do so, compared to individuals who were satisfied with their sense of belonging.

Conexiant

April 23, 2025

Life's Essential 8 Helps Predict CVD

"Greater cumulative CVH and improvement in CVH during young adulthood, as well as better CVH in middle age, were all independently associated with lower risk for incident CVD in midlife."

Conexiant

April 22, 2025

AHA Framework Maps HF Prevention Strategy

“The growing morbidity, mortality, and health care costs related to heart failure underscore the urgent need to prioritize its primary prevention.”

Conexiant

April 22, 2025

Dual Therapy Lowers Death Risk in Diabetes Study

A large study found that combining GLP-1 receptor agonists with thiazolidinediones significantly reduced death and heart risks in patients with type 2 diabetes.

Conexiant